800
Participants
Start Date
August 17, 2022
Primary Completion Date
August 31, 2026
Study Completion Date
September 30, 2026
enoxaparin/tinzaparin/dalteparin
Patients randomized to the preoperative thromboprophylaxis will have their thromboprophylaxis initiated approximately 2-14 hours prior to the planned pancreatic surgery skin incision (depending on the center's current practice and logistics). Thromboprophylaxis can be initiated using enoxaparin (20 - 40 mg), tinzaparin (2500 - 4500 IU), or dalteparin (2500 - 5000 IU), with the dose based on patient's renal function according to the local standard of care. A center may reduce the dose 25-50% if the dose is given very close to the skin incision (i.e. at the morning of the operation instead of the evening before the operation).
RECRUITING
Sunnybrook Health Sciences Centre, Toronto
RECRUITING
Helsinki University Hospital, Helsinki
RECRUITING
Oulu University Hospital, Oulu
RECRUITING
Tampere University Hospital, Tampere
RECRUITING
Oslo University Hospital, Oslo
Helsinki University Central Hospital
OTHER